Zenas BioPharma, Inc.
ZBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51,499 | -$52,223 | -$33,573 | -$52,604 |
| Dep. & Amort. | $11 | -$923 | $23 | $33 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $6,045 | $5,386 | $5,495 |
| Change in WC | -$3,664 | $5,158 | -$8,858 | $8,866 |
| Other Non-Cash | $14,027 | $200 | -$29 | -$344 |
| Operating Cash Flow | -$41,125 | -$41,743 | -$37,051 | -$38,554 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$18 | -$74 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$59,195 | -$126,553 | -$99,114 | -$9,661 |
| Inv. Sales/Matur. | $104,238 | $14,262 | $12,858 | $6,000 |
| Other Inv. Act. | -$5,000 | $0 | $0 | $0 |
| Investing Cash Flow | $40,043 | -$112,291 | -$86,274 | -$3,735 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $940 | $1,722 | $99 | $6,249 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $71,676 | $0 | $0 | -$4,396 |
| Financing Cash Flow | $72,616 | $1,722 | $99 | $1,853 |
| Forex Effect | $25 | -$236 | -$52 | $141 |
| Net Chg. in Cash | $71,559 | -$152,548 | -$123,278 | -$40,295 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44,006 | $196,554 | $319,832 | $360,127 |
| End Cash | $115,565 | $44,006 | $196,554 | $319,832 |
| Free Cash Flow | -$41,125 | -$41,743 | -$37,069 | -$38,628 |